Cesca Therapeutics, Inc.
(NASDAQ : KOOL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-1.64%106.060.6%$503.95m
ABTAbbott Laboratories
-2.87%81.950.8%$383.00m
TMOThermo Fisher Scientific Inc.
-3.24%269.151.0%$365.75m
ALGNAlign Technology, Inc.
-2.20%175.046.3%$331.79m
ISRGIntuitive Surgical, Inc.
-3.14%484.582.4%$277.10m
BDXBecton, Dickinson and Company
-2.64%248.441.1%$274.53m
EWEdwards Lifesciences Corporation
-2.10%212.121.2%$225.03m
SYKStryker Corporation
-1.90%214.121.3%$224.61m
ZBHZimmer Biomet Holdings, Inc.
-2.43%133.781.7%$198.44m
BSXBoston Scientific Corporation
-3.49%41.201.1%$196.69m
BAXBaxter International Inc.
-2.42%85.101.7%$184.94m
DXCMDexCom, Inc.
-0.47%173.558.3%$172.32m
ABMDABIOMED, Inc.
-2.99%189.593.3%$153.79m
WATWaters Corporation
-2.36%205.034.0%$113.59m
IDXXIDEXX Laboratories, Inc.
-3.37%270.443.7%$106.89m

Company Profile

Cesca Therapeutics, Inc. engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine. It operates through the following segments: Device and Clinical Development. The Device segment includes development and commercialization of automated systems that provide good manufacturing practice, clinical grade cell-banking, cell-processing and cell-based therapeutics. The Clinical Development segment develops autologous stem cell-based therapeutics that address significant unmet medical needs for the vascular, cardiology, and orthopedic markets. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.